Jinoos Yazdany
@jyazdanymd.bsky.social
Professor at UCSF, Chief of Rheumatology at SF General Hospital, using data analytics to improve the quality, safety, and equity of health care. Specialize in lupus.
Reposted by Jinoos Yazdany
Thrilled to share our new paper comparing different LLMs to extract TNFi reasons and treatment trajectories from UCSF de-identified EHR data with @bmeow19.bsky.social, A. Garcia-Agundez and @jyazdanymd.bsky.social published in JAMIA open.
academic.oup.com/jamiaopen/ar...
@ucsf-bchsi.bsky.social
academic.oup.com/jamiaopen/ar...
@ucsf-bchsi.bsky.social
November 14, 2025 at 9:36 PM
Thrilled to share our new paper comparing different LLMs to extract TNFi reasons and treatment trajectories from UCSF de-identified EHR data with @bmeow19.bsky.social, A. Garcia-Agundez and @jyazdanymd.bsky.social published in JAMIA open.
academic.oup.com/jamiaopen/ar...
@ucsf-bchsi.bsky.social
academic.oup.com/jamiaopen/ar...
@ucsf-bchsi.bsky.social
Reposted by Jinoos Yazdany
Cross-sectional study of adults with SLE in the US estimated 56.3% had polypharmacy (≥5 prescription or OTC meds).
Arthritis Care & Research
doi.org/10.1002/acr....
Arthritis Care & Research
doi.org/10.1002/acr....
October 29, 2025 at 9:47 PM
Cross-sectional study of adults with SLE in the US estimated 56.3% had polypharmacy (≥5 prescription or OTC meds).
Arthritis Care & Research
doi.org/10.1002/acr....
Arthritis Care & Research
doi.org/10.1002/acr....
Reposted by Jinoos Yazdany
🎉 We're honored to present the Evelyn V. Hess Award to Dr. Karen Costenbader for advancing #lupus research and care, and the Mary Betty Stevens Prize to Dr. Andrea Fava for innovative research driving progress in lupus science.
Learn more about their research: buff.ly/cn8xViK
Learn more about their research: buff.ly/cn8xViK
October 27, 2025 at 7:56 PM
🎉 We're honored to present the Evelyn V. Hess Award to Dr. Karen Costenbader for advancing #lupus research and care, and the Mary Betty Stevens Prize to Dr. Andrea Fava for innovative research driving progress in lupus science.
Learn more about their research: buff.ly/cn8xViK
Learn more about their research: buff.ly/cn8xViK
Friends today but not tomorrow - come to the #ACR25 Great Debate Monday at 8:30 am on #AI in #Rheumatology!!!
October 26, 2025 at 5:09 PM
Friends today but not tomorrow - come to the #ACR25 Great Debate Monday at 8:30 am on #AI in #Rheumatology!!!
Reposted by Jinoos Yazdany
Reposted by Jinoos Yazdany
Reposted by Jinoos Yazdany
Thrilled to see my book on healthcare Al available for preorder! sites.prh.com/preview/6f5c...
I tried to cut through the hype, with stories & insights on everything from scribes to surgery, hallucinations to misinformation, med education to regulation. Plus "Will there be doctors?"@portfoliobooks
I tried to cut through the hype, with stories & insights on everything from scribes to surgery, hallucinations to misinformation, med education to regulation. Plus "Will there be doctors?"@portfoliobooks
June 27, 2025 at 8:31 PM
Thrilled to see my book on healthcare Al available for preorder! sites.prh.com/preview/6f5c...
I tried to cut through the hype, with stories & insights on everything from scribes to surgery, hallucinations to misinformation, med education to regulation. Plus "Will there be doctors?"@portfoliobooks
I tried to cut through the hype, with stories & insights on everything from scribes to surgery, hallucinations to misinformation, med education to regulation. Plus "Will there be doctors?"@portfoliobooks
If the U.S. government wants to save $$$, they should read our article on #biosimilars: link.springer.com/article/10.1...
Breaking Barriers: Essential Reforms for a Competitive and Affordable Biosimilars Market - Current Rheumatology Reports
Purpose of review This update examines the current policy landscape for biosimilars, particularly those approved for treating rheumatoid arthritis. We review recent literature and recommend policies t...
link.springer.com
June 2, 2025 at 2:38 AM
If the U.S. government wants to save $$$, they should read our article on #biosimilars: link.springer.com/article/10.1...
Reposted by Jinoos Yazdany
NEW Episode of the ACR Journals on Air podcast! 🎙️
Epidemiology meets clinical care—Laura Plantinga, PhD, shares insights from her research on #lupus & daily activity limitations
🎧 Listen → acr.tw/4dE1lHe
Read the study → doi.org/10.1002/acr....
#Medsky
Epidemiology meets clinical care—Laura Plantinga, PhD, shares insights from her research on #lupus & daily activity limitations
🎧 Listen → acr.tw/4dE1lHe
Read the study → doi.org/10.1002/acr....
#Medsky
May 31, 2025 at 10:26 PM
NEW Episode of the ACR Journals on Air podcast! 🎙️
Epidemiology meets clinical care—Laura Plantinga, PhD, shares insights from her research on #lupus & daily activity limitations
🎧 Listen → acr.tw/4dE1lHe
Read the study → doi.org/10.1002/acr....
#Medsky
Epidemiology meets clinical care—Laura Plantinga, PhD, shares insights from her research on #lupus & daily activity limitations
🎧 Listen → acr.tw/4dE1lHe
Read the study → doi.org/10.1002/acr....
#Medsky
Reposted by Jinoos Yazdany
Miss the conversation on bias in healthcare AI?
🎥 Catch Paige Nong, @ajh.bsky.social, and @ryan-levi.bsky.social as they unpack real-world risks—and what it takes to evaluate AI tools responsibly.
See how the experts broke it down: codex.ucsf.edu/events/codex...
@tradeoffs.org
🎥 Catch Paige Nong, @ajh.bsky.social, and @ryan-levi.bsky.social as they unpack real-world risks—and what it takes to evaluate AI tools responsibly.
See how the experts broke it down: codex.ucsf.edu/events/codex...
@tradeoffs.org
🌟Register for CODEX's April webinar!
What happens when AI tools in hospitals carry bias? And how can we prevent it?
Join top researchers to talk about bias in health AI: what it looks like, who's testing for it, and what hospitals can do.
🗓️ April 30 | 9-10 a.m. PT
🔗 codex.ucsf.edu/events/codex...
What happens when AI tools in hospitals carry bias? And how can we prevent it?
Join top researchers to talk about bias in health AI: what it looks like, who's testing for it, and what hospitals can do.
🗓️ April 30 | 9-10 a.m. PT
🔗 codex.ucsf.edu/events/codex...
May 1, 2025 at 4:17 PM
Miss the conversation on bias in healthcare AI?
🎥 Catch Paige Nong, @ajh.bsky.social, and @ryan-levi.bsky.social as they unpack real-world risks—and what it takes to evaluate AI tools responsibly.
See how the experts broke it down: codex.ucsf.edu/events/codex...
@tradeoffs.org
🎥 Catch Paige Nong, @ajh.bsky.social, and @ryan-levi.bsky.social as they unpack real-world risks—and what it takes to evaluate AI tools responsibly.
See how the experts broke it down: codex.ucsf.edu/events/codex...
@tradeoffs.org
Reposted by Jinoos Yazdany
Excellent career advice from Peter Hotez journals.plos.org/plosbiology/.... Also some good stuff here for universities to consider in the face of current challenges.
Navigating your US bioscience career into the 2030s
The coming decade might see major cuts to US Government funding for biomedicine and the mainstreaming of pseudoscience. This Perspective highlights how your biosciences PhD gives you the problem-solvi...
journals.plos.org
March 30, 2025 at 5:14 PM
Excellent career advice from Peter Hotez journals.plos.org/plosbiology/.... Also some good stuff here for universities to consider in the face of current challenges.
I’m excited to take on this new role and do my small smart to make sure AI is safe, fair, and effective. Best part is getting to work with visionary leaders like @julia-adler-mils.bsky.social @saramurray.bsky.social @sarahpollet.bsky.social and many others
🚨 Big news in AI & healthcare! Jinoos Yazdany, MD, MPH, has been named Executive Director of AI Monitoring in Clinical Care at UCSF. She’ll lead efforts to ensure AI tools are evaluated and deployed safely and effectively. Read more: docit.ucsf.edu/news/jinoos-...
@jyazdanymd.bsky.social
@jyazdanymd.bsky.social
March 19, 2025 at 5:47 PM
I’m excited to take on this new role and do my small smart to make sure AI is safe, fair, and effective. Best part is getting to work with visionary leaders like @julia-adler-mils.bsky.social @saramurray.bsky.social @sarahpollet.bsky.social and many others
Reposted by Jinoos Yazdany
🚨 Big news in AI & healthcare! Jinoos Yazdany, MD, MPH, has been named Executive Director of AI Monitoring in Clinical Care at UCSF. She’ll lead efforts to ensure AI tools are evaluated and deployed safely and effectively. Read more: docit.ucsf.edu/news/jinoos-...
@jyazdanymd.bsky.social
@jyazdanymd.bsky.social
March 19, 2025 at 4:10 PM
🚨 Big news in AI & healthcare! Jinoos Yazdany, MD, MPH, has been named Executive Director of AI Monitoring in Clinical Care at UCSF. She’ll lead efforts to ensure AI tools are evaluated and deployed safely and effectively. Read more: docit.ucsf.edu/news/jinoos-...
@jyazdanymd.bsky.social
@jyazdanymd.bsky.social
I've been waiting for this one!!!
www.nejm.org/doi/full/10....
🆕Obinutuzumab(humanized anti-CD20 monoclonal antibody) in active #lupus nephritis 🫘
👉Phase3
📖NEJM
#Rheumsky #lupusnephritis
🆕Obinutuzumab(humanized anti-CD20 monoclonal antibody) in active #lupus nephritis 🫘
👉Phase3
📖NEJM
#Rheumsky #lupusnephritis
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis | NEJM
Obinutuzumab, a humanized type II anti-CD20 monoclonal antibody, provided significantly better renal responses than placebo in a phase 2 trial involving patients with lupus nephritis receiving stan...
www.nejm.org
February 7, 2025 at 10:18 PM
I've been waiting for this one!!!
Reposted by Jinoos Yazdany
Somewhere in the U.S., there’s a scientist staring at their NSF/NIH grant application wondering why they bother. This post is for you. Science and society both need you. Hang in there and know there is a whole community supporting you.
January 29, 2025 at 4:52 PM
Somewhere in the U.S., there’s a scientist staring at their NSF/NIH grant application wondering why they bother. This post is for you. Science and society both need you. Hang in there and know there is a whole community supporting you.
Reposted by Jinoos Yazdany
Fantastic, super clear explanation by Dr. Choo of NIH grants process: takes “tens of thousands of reviewers annually on more than 1000 meetings with study sections like the one I should have been sitting in Thursday.” Even if/when the freeze ends, can’t just be restarted with a snap.
🧪
🧪
An explainer about how health research funding happens and why this NIH funding cycle shutdown matters: www.msnbc.com/opinion/msnb...
Opinion | I’m a health researcher. NIH’s pause on research grants could have a devastating cost.
This is a potentially devastating event — not just for the scientific community, but for all Americans.
www.msnbc.com
January 28, 2025 at 6:48 PM
Fantastic, super clear explanation by Dr. Choo of NIH grants process: takes “tens of thousands of reviewers annually on more than 1000 meetings with study sections like the one I should have been sitting in Thursday.” Even if/when the freeze ends, can’t just be restarted with a snap.
🧪
🧪
Reposted by Jinoos Yazdany
Health Disparities are real & lethal. Research on ⬇️ health disparities & improving health among impacted pops is critical. The NIMHD (NIH Institute that focuses on ⬇️ disparities) website remains. But if you search NIH Health Disparities, the page is gone. Chilling.
January 25, 2025 at 9:11 PM
Health Disparities are real & lethal. Research on ⬇️ health disparities & improving health among impacted pops is critical. The NIMHD (NIH Institute that focuses on ⬇️ disparities) website remains. But if you search NIH Health Disparities, the page is gone. Chilling.
Reposted by Jinoos Yazdany
Extremely pleased to see this published! It takes a whole division of rheumatology to be on the look out for active SLE patients in the clinics/hospital with an active flare to enroll them in research and follow them over time
clinicalepigeneticsjournal.biomedcentral.com/articles/10....
clinicalepigeneticsjournal.biomedcentral.com/articles/10....
Changes in DNA methylation are associated with systemic lupus erythematosus flare remission and clinical subtypes - Clinical Epigenetics
Background Systemic lupus erythematosus (SLE) has numerous symptoms across organs and an unpredictable flare-remittance pattern. This has made it challenging to understand drivers of long-term SLE out...
clinicalepigeneticsjournal.biomedcentral.com
December 19, 2024 at 2:45 AM
Extremely pleased to see this published! It takes a whole division of rheumatology to be on the look out for active SLE patients in the clinics/hospital with an active flare to enroll them in research and follow them over time
clinicalepigeneticsjournal.biomedcentral.com/articles/10....
clinicalepigeneticsjournal.biomedcentral.com/articles/10....
Reposted by Jinoos Yazdany
We have 2 fellowship positions available (1 pediatric rheumatology, 1 med-peds rheumatology) at the Children’s Hospital at Montefiore, Bronx, NY. We welcome #IMG and sponsor both J1 and H1b visas. You will never regret being part of this outstanding team! See information below if interested!
December 5, 2024 at 12:05 AM
We have 2 fellowship positions available (1 pediatric rheumatology, 1 med-peds rheumatology) at the Children’s Hospital at Montefiore, Bronx, NY. We welcome #IMG and sponsor both J1 and H1b visas. You will never regret being part of this outstanding team! See information below if interested!
Dr. Jenny Mandal's Rheumatology Access Expansion (RAE: raeinitiative.org) has trained 111 primary care clinicians on Native American reservations around the U.S. to care for people with #RA. Read about her inspiring work at the link below. #rheumsky #UCSFrheum
November 29, 2024 at 10:29 PM
Dr. Jenny Mandal's Rheumatology Access Expansion (RAE: raeinitiative.org) has trained 111 primary care clinicians on Native American reservations around the U.S. to care for people with #RA. Read about her inspiring work at the link below. #rheumsky #UCSFrheum
This trial is very interesting - we need ways to prevent LN before it happens! Early MMF helps but for how long should rx continue? Also need to further define who will benefit. jamanetwork.com/journals/jam...
Mycophenolate Mofetil and New-Onset Systemic Lupus Erythematosus
This randomized clinical trial investigates whether early application of mycophenolate mofetil improves long-term outcomes in patients with newly diagnosed systemic lupus erythematosus with a high tit...
jamanetwork.com
November 23, 2024 at 6:54 PM
This trial is very interesting - we need ways to prevent LN before it happens! Early MMF helps but for how long should rx continue? Also need to further define who will benefit. jamanetwork.com/journals/jam...
#ACR24 Older patients, those in low nSES areas, and certain racial/ethnic groups less likely to get b/tsDMARDs, trends that did not change over last decade.#RISE-registry. www.heal.com/news/rheumat...
Age, racial gaps in b/tsDMARD use for rheumatoid arthritis show ‘surprising’ stability
WASHINGTON — Disparities in the use of biologic and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis, including among older, Black and Asian patients, have not c...
www.healio.com
November 21, 2024 at 3:21 PM
#ACR24 Older patients, those in low nSES areas, and certain racial/ethnic groups less likely to get b/tsDMARDs, trends that did not change over last decade.#RISE-registry. www.heal.com/news/rheumat...
Reposted by Jinoos Yazdany
For the second year, @ACRheum’s Global Engagement Committee along with @rheum_covid leaders were able to review over 60 applications and provide travel awards to these accomplished individuals to attend #ACR24
November 20, 2024 at 2:37 AM
For the second year, @ACRheum’s Global Engagement Committee along with @rheum_covid leaders were able to review over 60 applications and provide travel awards to these accomplished individuals to attend #ACR24